Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
nLife Therapeutics
company
About
nLife Therapeutics is a biopharmaceutical development company that develops treatments for CNS diseases.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €2M
- Industries
- Biotechnology,Ediscovery
- Founded date
- Jan 1, 2009
- Number Of Employee
- 11 - 50
- Operating Status
- Active
nLife Therapeutics, S.L., a Granada, Spain-based company that develops innovative tratments for CNS diseases. The company intends to use the funds to advance clinical trials for its treatments.nLife Therapeutics is working on next generation targeted nucleic acids products. Its technology delivers conjugated nucleic acids with small chemicals to selected neurons after a single intra-nasal application.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€7M
nLife Therapeutics has raised a total of
€7M
in funding over 2 rounds. Their latest funding was raised on
Jun 20, 2014 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 20, 2014 | Series Unknown | €2M | 1 | — | — | Detail |
| Feb 21, 2012 | Series Unknown | €5M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
nLife Therapeutics is funded by 1 investors.
Invercaria
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Invercaria
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
